獸醫市場

Abstract

Profound changes are happening in the animal health market. Pet owners in the United States are demanding more advanced and expensive treatments for companion animals, driving growth in the companion-animal sector. At the same time, concerns about livestock health care and feeding are driving changes in industrial animal husbandry. This TriMark Publications report offers a broad, yet detailed, overview of the shape of the veterinary health products market over the next several years. Examining both livestock and companion-animal markets. The overall market for veterinary therapeutics and diagnostic products has grown dramatically. This report analyzes the U.S. veterinary pharmaceuticals and diagnostics markets. The report outlines market size, market growth, forecasts, and competitive information. Focusing both on companion (pet) animal markets and agricultural livestock, the report examines the markets for pharmaceuticals, vaccines, diagnostics, and feed additives. The study reveals: the size of the markets for companion-animal products, broken down by type of animal (i.e., cats, dogs, small animals, etc.); size of the markets for livestock products; how the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) regulations impact these markets; the identity of the top market players, along with their market shares and future prospects; how the antibiotic feed additive controversy is influencing the agricultural market; and key players in the veterinary pharma and diagnostic markets.

Table of Contents

1. Overview

• 1.1 Objective of Report
• 1.2 Scope of Report
• 1.3 Methodology
• 1.4 Executive Summary

2. Veterinary Biological Products

• 2.1 Overview of Health Products Market
  • 2.1.1 World Products Markets
  • 2.1.2 U.S. Animal Health Products Market
  • 2.1.3 European Animal Health Markets
  • 2.1.4 Asian Animal Health Products Markets
  • 2.1.5 World Market Share
  • 2.1.6 Common Animal Diseases
  • 2.1.7 Companion Animals
• 2.2 Veterinary Vaccines
  • 2.2.1 Major Canine Vaccines
  • 2.2.2 Major Feline Vaccines
• 2.3 Agricultural Animals
  • 2.3.1 Major Cattle Vaccines
  • 2.3.2 Major Poultry Vaccines
  • 2.3.3 Major Sheep Vaccines
  • 2.3.4 Major Swine Vaccines
  • 2.3.5 Horses
• 2.4 Trends in the Biologicals Market
• 2.5 Nutraceuticals
  • 2.5.1 Nutraceutical Market for Companion Animals
• 2.6 OTC Animal Health Global Market Opportunity

3. Veterinary Pharmaceutical Products

• 3.1 Overview
  • 3.1.1 Pharmaceutical Products for Dogs and Cats
    • 3.1.1.1 Antiparasites
    • 3.1.1.2 Antibiotics
    • 3.1.1.3 Anti-Inflammatories
    • 3.1.1.4 Chronic Care Products
    • 3.1.1.5 Cardiovasculars
    • 3.1.1.6 GI Products
    • 3.1.1.7 Endocrine Products
    • 3.1.1.8 Anti-Infectives
    • 3.1.1.9 Behavior Modifiers
    • 3.1.1.10 Anthelmimetics
    • 3.1.1.11 Antifungals
  • 3.1.2 Pharmaceutical Products for Agricultural Animals
    • 3.1.2.1 Antiparasites
    • 3.1.2.2 Antibiotics
    • 3.1.2.3 Insecticides
• 3.2 Leading Products and Competitors
  • 3.2.1 Elanco
  • 3.2.2 Novartis
  • 3.2.3 Alpharma
  • 3.2.4 Wyeth
  • 3.2.5 Pfizer Animal Health
• 3.3 Veterinary Pharmaceutical Market Trends
• 3.4 Companion-Animal Crossover Products
• 3.5 Generics in the Animal Health Sector

4. Veterinary Feed Additive Products

• 4.1 Overview
• 4.2 U.S. Feed Additives Market
• 4.3 Leading Feed Additives and Competitors
• 4.4 Feed Additives Market Trends
  • 4.4.1 Livestock Performance Enhancers
• 4.5 Pet Food Additives and Contaminants
  • 4.5.1 Pet Deaths
  • 4.5.2 The FDA Response

5. Veterinary Diagnostic Test Products

• 5.1 Introduction
• 5.2 Veterinary Diagnostic Market Size and Growth Rates
  • 5.2.1 Market Drivers
  • 5.2.2 Immunodiagnostic and Nucleic Acid Testing Markets
    • 5.2.2.1 Market Size and Growth
  • 5.2.3 Technological Developments in the Diagnostic Industry
• 5.3 Competitive Situation
• 5.4 Estimate of Units Sold and Pricing
• 5.5 PCR Applications for Veterinary Use
• 5.6 Companion-Animal Diagnostics
  • 5.6.1 Feline Leukemia Virus
• 5.7 Agricultural Animal Diagnostics
• 5.8 U.S. Diagnostic Test Market
• 5.9 Leading Competitors in Diagnostic Testing
• 5.10 Veterinary Diagnostic Market Trends
• 5.11 Collaborative Licensing
• 5.12 BSE Diagnostic Tests
• 5.13 West Nile Virus Diagnostic Tests
• 5.14 Avian Flu Diagnostic Tests

6. Overview of the Veterinary Health Market

• 6.1 Regulatory Environment
  • 6.1.1 Regulation of Animal Health Products in the E.U.
  • 6.1.2 Regulation of Animal Health Products in Japan
    • 6.1.2.1 Regulatory Environment
    • 6.1.2.2 Withdrawal Periods
    • 6.1.2.3 Filing Procedures for New Animal Drug Applications
    • 6.1.2.4 Use of Outdated Animal Studies
    • 6.1.2.5 Brand-Specific Listing for Antimicrobial Antibiotic and Other Feed Additives
  • 6.1.3 Proposed Regulation of Animal Antibiotics
• 6.2 The European Animal Health Industry
  • 6.2.1 Trends Driving Demand
    • 6.2.1.1 European, International and U.S. Oversight of Veterinary Medicines
    • 6.2.1.2 Antibiotic Usage
• 6.3 Mergers and Acquisitions
• 6.4 New Product Launches
• 6.5 Bioterrorism and Foodborne Pathogens„oWHO Guidelines
• 6.6 Generic Products

7. Emerging Markets

• 7.1 Biotechnology and Veterinary Health
  • 7.1.1 Biotechnology and Biologics
    • 7.1.1.1 Recombinant DNA Vaccines
    • 7.1.1.2 Plant-Derived Vaccines
  • 7.1.2 DNA Probes
  • 7.1.3 Biotechnology and Pharmaceuticals
    • 7.1.3.1 Immune System Augmentation
    • 7.1.3.2 Growth Enhancers
• 7.2 Impact of Genomics on Veterinary Health
  • 7.2.1 Autosomal Dominant Traits
  • 7.2.2 X-Linked Traits
  • 7.2.3 Autosomal Recessive Traits
  • 7.2.4 Current DNA Testing in Animals
  • 7.2.5 Direct DNA Testing: Mutation-Based Tests
  • 7.2.6 Indirect DNA Testing: Linkage-Based or Marker-Based Tests
• 7.3 Companion-Animal Markets
• 7.4 Alternative Medicine in Veterinary Practice

8. Company Profiles

• 8.1 Abaxis, Inc.
• 8.2 Abbott Laboratories
• 8.3 Adiagene
• 8.4 Agricultural Research Service
• 8.5 Alpharma, Inc.
• 8.6 Avian Biotech
• 8.7 BASF Agricultural Products and Nutrition
• 8.8 Bayer Animal Health
• 8.9 Biobest Diagnostics
• 8.10 BioVet, Inc.
• 8.11 Boehringer Ingelheim Corp.
• 8.12 Cypress Diagnostics
• 8.13 DayMoon Industries, Inc.
• 8.14 Dow AgroSciences LLC
• 8.15 Dupont Qualicon
• 8.16 Elanco Animal Health
• 8.17 Fort Dodge Animal Health
• 8.18 Gene Check, Inc.
• 8.19 Gene-Trak
• 8.20 Heska Animal Health
• 8.21 IDEXX Laboratories, Inc.
• 8.22 IGEN International, Inc.
• 8.23 IMC Global, Inc.
• 8.24 Intervet International
• 8.25 IVAX Corporation
• 8.26 Laboklin
• 8.27 Medigenomix GmbH
• 8.28 Merial Animal Health
• 8.29 Microbix Biosystems, Inc.
• 8.30 Monsanto
• 8.31 Novartis Animal Health
• 8.32 OptiGen
• 8.33 PE AgGen/Celera AgGen
• 8.34 PETCO Animal Supplies, Inc.
• 8.35 PetSmart, Inc.
• 8.36 Pfizer Animal Health
• 8.37 Roche Animal Nutrition and Health
• 8.38 Sanofi-Aventis
• 8.39 Schering-Plough Animal Health Corporation
• 8.40 Synbiotics Corporation
• 8.41 VCA Antech, Inc.
• 8.42 Virbac SA
• 8.43 Wyeth

9. Business Trends in the Industry

• 9.1 Animal Health Additive Growth Trends
• 9.2 Move to Complete Product Portfolio
• 9.3 Reduced Antibiotic Usage in Animal Feeds
• 9.4 European Animal Health Industry
• 9.5 Licensing and Partnership Opportunities in Animal Health R&D

10. Company Directory

Appendix 1: Dosages for Selected Drugs Alphabetical Listing

Appendix 2: Trade Names

Appendix 3: Nomenclature

INDEX OF FIGURES

• Figure 2.1: Worldwide Sales of Animal Health Products Market by Product Class, 2006
• Figure 2.2: Worldwide Animal Health Products Market by Region, 2006
• Figure 2.3: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2006
• Figure 3.1: Novartis Business Split
• Figure 3.2: Novartis Product Split
• Figure 3.3: Novartis Geographic Split
• Figure 4.1: Global Market for Livestock Performance Enhancers, 2006

LIST OF TABLES

• Table 2.1: World Market for Animal Health Products, 2004-2012
• Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012
• Table 2.3: Worldwide Animal Health Products Market by Region, 2006
• Table 2.4: U.S. Animal Health Product Sales, 2005-2012
• Table 2.5: Japanese Animal Health Market, 2000-2012
• Table 2.6: Chinese Animal Health Products Market, 2005-2012
• Table 2.7: Worldwide Animal Health Product Sales for Leading Producers, 2006
• Table 2.8: List A Diseases
• Table 2.9: List B Diseases
• Table 2.10: Cattle Diseases
• Table 2.11: Sheep and Goat Diseases
• Table 2.12: Equine Diseases
• Table 2.13: Swine Diseases
• Table 2.14: Avian Diseases
• Table 2.15: Fish Diseases
• Table 2.16: Other Veterinary Diseases
• Table 2.17: Leading Companion-Animal Prescription Drugs by Sales, 2006
• Table 2.18: Worldwide Veterinary Vaccine Market, 2005-2012
• Table 2.19: U.S. Veterinary Vaccine Market, 2000-2008
• Table 2.20: Canine Vaccinations
• Table 2.21: Dog Vaccine Price List
• Table 2.22: Global Market for Nutraceutical in Companion Animals, 2005-2012
• Table 3.1: Veterinary Drugs Listed by Therapeutic Class
• Table 3.2: Animal Health Product Sales in the U.S., 2000-2008
• Table 3.3: Sales of Pharmaceutical Products for Animal Health in the U.S., 2000-2008
• Table 3.4: Number of Dogs in the U.S., 1996, 2001 and 2006
• Table 3.5: Number of Pet Dogs by Country
• Table 3.6: Number of Cats in the U.S., 1996, 2001 and 2006
• Table 3.7: Number of Pet Cats by Country
• Table 3.8: U.S. Spending on Pet Care, 1996, 2001 and 2006
• Table 3.9: American Veterinary Board Certified Diplomats
• Table 3.10: Companion-Animal Products in Excess of $ 1 Billion Sales
• Table 3.11: U.S. Antiparistic Animal Health Product Sales, 2005-2012
• Table 3.12: Worldwide Sales of Animal Health Antibiotics, 2005-2012
• Table 3.13: U.S. Volume of Animal Health Antibiotics Used, 2000-2006
• Table 3.14: U.S. Sales of Animal Health Antibiotics, 2005-2012
• Table 3.15: Common Veterinary Anti-Inflammatories
• Table 3.16: U.S. Pet Anti-Inflammatory Market, 2000-2009
• Table 3.17: Retail Pricing of Rimadyl
• Table 3.18: Etogesic Pricing
• Table 3.19: Bacterial and Protozoal Threats to Poultry
• Table 3.20: Bacterial and Protozoal Threats to Pigs
• Table 3.21: Elanco Veterinary Products Summary
• Table 3.22: Wyeth Fort Dodge Animal Health Products
• Table 4.1: Sales of Feed Additives for Animal Health in the U.S., 2001-2008
• Table 4.2: Feed Additives„oAntimicrobials and Growth Promotants
• Table 4.3: Feed Additives„oAnthelmintics
• Table 4.4: U.S. Sales of Animal Health Chemicals, 2001-2010
• Table 4.5: U.S. Beef Exports, 2001-2006
• Table 4.6: U.S. States Beef Production by State, 2003
• Table 4.7: Global Market for Livestock Performance Enhancers, 2004-2010
• Table 5.1: Veterinary Diagnostics World Market, 2005-2012
• Table 5.2: Veterinary Immunodiagnostic Testing World Markets, 2005-2012
• Table 7.1: Labs that Perform Canine DNA Testing
• Table 7.2: DNA (Mutation) Tests for Canine Inherited Diseases
• Table 7.3: DNA (Marker) Tests for Canine Inherited Diseases
• Table 8.1: Alpharma Revenue and Operating Income/Loss, 2001-2003
• Table 8.2: Alpharma Revenue and Operating Income/Loss and Discontinued Operations, 2004-2006
• Table 8.3: Pfizer Animal Health Products
• Table 8.4: Pfizer Products Patents
• Table 8.5: Key Pfizer Animal Health Products
• Table 8.6: Pfizer Livestock Products
• Table 8.7: Pfizer Equine Products
• Table 8.8: Pfizer Companion Animal Products
• Table 9.1: European Animal Health Market Sales, 2004-2010